Ray Dalio's BSX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 93,745 shares of Boston Scientific Corporation (BSX) worth $8.94 M, representing 0.03% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in BSX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2022, adding 818,484 shares. Largest reduction occurred in Q3 2024, reducing 815,182 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -65,984 | Reduce 41.31% | 93,745 | $95.35 |
| Q3 2025 | +111,445 | Add 230.81% | 159,729 | $97.63 |
| Q2 2025 | -15,670 | Reduce 24.50% | 48,284 | $107.41 |
| Q1 2025 | -98,959 | Reduce 60.74% | 63,954 | $100.88 |
| Q4 2024 | -193,851 | Reduce 54.34% | 162,913 | $89.32 |
| Q3 2024 | -815,182 | Reduce 69.56% | 356,764 | $83.80 |
| Q2 2024 | -172,553 | Reduce 12.83% | 1.17 M | $77.01 |
| Q1 2024 | -413,013 | Reduce 23.50% | 1.34 M | $68.49 |
| Q4 2023 | +22,416 | Add 1.29% | 1.76 M | $57.81 |
| Q3 2023 | -3,548 | Reduce 0.20% | 1.74 M | $52.80 |
| Q2 2023 | -203,590 | Reduce 10.48% | 1.74 M | $54.09 |
| Q1 2023 | -3,009 | Reduce 0.15% | 1.94 M | $50.03 |
| Q4 2022 | -640,797 | Reduce 24.78% | 1.95 M | $46.27 |
| Q3 2022 | +271,504 | Add 11.73% | 2.59 M | $38.73 |
| Q2 2022 | -331,476 | Reduce 12.53% | 2.31 M | $37.27 |
| Q1 2022 | +818,484 | Add 44.79% | 2.65 M | $44.29 |
| Q4 2021 | +287,729 | Add 18.69% | 1.83 M | $42.48 |
| Q3 2021 | -33,071 | Reduce 2.10% | 1.54 M | $43.39 |
| Q2 2021 | +597,739 | Add 61.30% | 1.57 M | $42.76 |
| Q1 2021 | +252,959 | Add 35.03% | 975,131 | $38.65 |
| Q4 2020 | +392,204 | Add 118.86% | 722,172 | $35.95 |
| Q3 2020 | +329,968 | New Buy | 329,968 | $38.21 |
| Q2 2020 | -15,808 | Sold Out | 0 | $0.00 |
| Q1 2020 | +15,808 | New Buy | 15,808 | $32.64 |
| Q4 2019 | -26,571 | Sold Out | 0 | $0.00 |
| Q3 2019 | +14,065 | Add 112.47% | 26,571 | $40.68 |
| Q2 2019 | -28,819 | Reduce 69.74% | 12,506 | $43.02 |
| Q1 2019 | +41,325 | New Buy | 41,325 | $38.38 |
| Q2 2018 | -100,850 | Sold Out | 0 | $0.00 |
| Q1 2018 | -75,229 | Reduce 42.72% | 100,850 | $27.32 |
| Q4 2017 | +176,079 | New Buy | 176,079 | $24.79 |
| Q1 2017 | -91,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | +40,100 | Add 78.78% | 91,000 | $21.63 |
| Q3 2016 | +41,216 | Add 425.61% | 50,900 | $23.79 |
| Q2 2016 | -26,500 | Reduce 73.24% | 9,684 | $23.34 |
| Q1 2016 | -52,100 | Reduce 59.01% | 36,184 | $18.82 |
| Q4 2015 | -15,400 | Reduce 14.85% | 88,284 | $18.44 |
| Q3 2015 | -14,700 | Reduce 12.42% | 103,684 | $16.41 |
| Q2 2015 | +7,300 | Add 6.57% | 118,384 | $17.70 |
| Q1 2015 | +21,900 | Add 24.56% | 111,084 | $17.75 |
| Q4 2014 | +27,800 | Add 45.29% | 89,184 | $13.25 |
| Q3 2014 | +61,384 | New Buy | 61,384 | $11.81 |
| Q2 2014 | -36,884 | Sold Out | 0 | $0.00 |
| Q1 2014 | -86,700 | Reduce 70.15% | 36,884 | $13.53 |
| Q4 2013 | +123,584 | New Buy | 123,584 | $12.02 |
Ray Dalio's Boston Scientific Corporation Investment FAQs
Ray Dalio first purchased Boston Scientific Corporation (BSX) in Q4 2013, acquiring 123,584 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Boston Scientific Corporation (BSX) for 45 quarters since Q4 2013.
Ray Dalio's largest addition to Boston Scientific Corporation (BSX) was in Q1 2022, adding 2,646,012 shares worth $117.19 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 93,745 shares of Boston Scientific Corporation (BSX), valued at approximately $8.94 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Boston Scientific Corporation (BSX) was 2,646,012 shares, as reported at the end of Q1 2022.